Weight Loss A highly desired benefit of GLP-1 receptor agonists, such as Wegovy, is their effectiveness in promoting weight loss
Reema Arora, patients receive personalised protocols using established medical options such as laser tone correction, chemical peels, topical medical skincare, and regenerative injectables including exosomes (and glutathione where clinically appropriate), guided by AI-assisted skin analysis for precision and safety
In higher cost areas or less competitive markets it could be $250/month or more
Regeneron, Amgen, and even Ozempic maker Novo Nordisk itself are developing new weight loss drugs as demand soars The race is intensifying among pharmaceutical companies aiming to disrupt the weight loss drug duopoly dominated by Novo Nordisk, known for making Ozempic and Wegovy, and Eli Lilly $LLY, the producer of Zepbound